Ads
related to: hyperparathyroidism medication
Search results
Results from the WOW.Com Content Network
Treatment: Monitoring, surgery, intravenous normal saline, cinacalcet [1] [2] Frequency ~2 per 1,000 [3] Hyperparathyroidism is an increase in parathyroid hormone ...
Tertiary hyperparathyroidism is a condition involving the overproduction of the hormone, parathyroid hormone, produced by the parathyroid glands. [1] The parathyroid glands are involved in monitoring and regulating blood calcium levels and respond by either producing or ceasing to produce parathyroid hormone.
Primary hyperparathyroidism (or PHPT) is a medical condition where the parathyroid gland (or a benign tumor within it) produce excess amounts of parathyroid hormone (PTH). ). The symptoms of the condition relate to the resulting elevated serum calcium (hypercalcemia), which can cause digestive symptoms, kidney stones, psychiatric abnormalities, and bone dis
Calcimimetics are used to treat secondary hyperparathyroidism (SHPT). [1] [2] In the treatment of SHPT patients on dialysis calcimimetics does not appear to affect the risk of early death. [3] It does decrease the need for a parathyroidectomy but caused more issues with low blood calcium levels and vomiting. [3]
If the underlying cause of the hypocalcemia can be addressed, the hyperparathyroidism will resolve. In people with chronic kidney failure, treatment consists of dietary restriction of phosphorus; supplements containing an active form of vitamin D, such as calcitriol, doxercalciferol, paricalcitol; and phosphate binders, which are either calcium-based and non-calcium based.
Etelcalcetide, sold under the brand name Parsabiv, is a calcimimetic medication for the treatment of secondary hyperparathyroidism in people undergoing hemodialysis. It is administered intravenously at the end of each dialysis session. [3] [4] Etelcalcetide functions by binding to and activating the calcium-sensing receptor in the parathyroid ...
Ads
related to: hyperparathyroidism medication